To Top

Press Release


Alkem receives EIR from the US FDA for its Daman formulation facility December 23, 2016

Update on USFDA inspection at Ankleshwar API facility December 12, 2016

Q2FY17 Financial Results November 11, 2016

Q2FY17 Press Release and Investor Presentation November 11, 2016

Q2FY17 Conference Call Invite November 07, 2016

Update on US FDA Bio-analytical Inspection at Daman Facility October 28, 2016

Update on US FDA inspection at Daman Facility September 29, 2016

Q1FY17 Financial Results August 12, 2016

Q1FY17 Press Release and Investor Presentation August 12, 2016

Successful US FDA Inspection at Alkem's Bioequivalence Facility at Taloja August 11, 2016

Q1FY17 Conference Call Invite August 02, 2016

EMA recommendations June 2016 June 25, 2016

Clarification on News Report June 09, 2016

Closure of UK MHRA inspection for Bioequivalence Facility at Taloja June 07, 2016

Q4FY16 Press Release May 27, 2016

Q4FY16 & FY16 Financial Results May 27, 2016

Favourable Competition Appellate Tribunal Order May 10, 2016

Q4 & FY16 Conference Call Invite May 10, 2016

Clarification April 16, 2016

UK MHRA Inspection - Update March 31, 2016

Declaration of Interim Dividend and Record Date March 09, 2016

Alkem's Mandva Plant successfully obtains the Establishment Inspection Report from the US FDA March 07, 2016

Financial Results, Limited Review Report for December 31, 2015 February 12, 2016

Authorised KMPs to determine materiality of events or information February 12, 2016

Press Release and Analyst presentation on Q3FY16 Results February 12, 2016